In the context of pulmonary fibrosis, we observed a significant rise in ANRIL expression, consistent with previous studies that reported heightened ANRIL levels in fibrotic tissues [29–31]. This evidence concerns the gene CDKN2B-AS1 and pulmonary fibrosis.